Founder and President, Mark Newman, to Speak at Rescheduled A4M Spring World Congress


McMinnville, OR — (April 2, 2020) –  

In the wake of COVID-19 pandemic, the American Academy of Anti-Aging Medicine (A4M) has rescheduled their 28th Annual Spring World Congress, originally to be held on May 14-16th, to August 20-22 at the Gaylord Palms Resort & Convention Center in Orlando.

A4M invited Precision Analytical Inc. founder and president, Mark Newman, to present his lecture on The Mystery of Lab Assessments and Transdermal Hormone Replacement Treatment, and the invitation still stands for the new dates. Mark was chosen to speak from over 200 submitted abstracts, A4M’s most competitive year yet!

A4M is a nonprofit holding two annual World Congress conferences, one in the spring in Florida and another in the winter in Las Vegas, each hosting 3-5,000 physicians and healthcare practitioners. Through the World Congress, A4M continues to deliver world-class education focused on integrative health through the most recently emerging clinical research, newly discovered therapies, and future scientific advances. 

Designed to take A4M’s mission of redefining medicine to the next level, the Spring Congress 2020 will examine new ways in which medical professionals can actively build a new standard of health care. Rooted in outcome-driven practices, protocols, and research, this anti-aging conference is dedicated to real, transformative results. The Spring Congress 2020 will administer the latest clinical education within a wide variety of specialties. Through interactive lectures and advanced educational opportunities grounded in breakthrough clinical research and analysis, this conference will propel physician-led, patient-centered care into the forefront of the new decade.

Mark’s presentation will lead listeners through a transparent discussion about the challenges of monitoring transdermal hormones. This is a topic with a wide array of opinions and practices throughout the industry due to the tremendous amount of confusion regarding hormone replacement therapy (HRT), especially for transdermal hormones. Mark has a unique perspective on this subject matter and has invested a great deal of time in researching the issue. His talk will help explain the clinical data which should shape dosing and monitoring practices, and healthcare practitioners will leave Mark’s presentation better equipped to handle the challenges of HRT monitoring with more understanding of the HRT scenarios where lab testing does not assist the provider’s evaluation of therapy.

About Precision Analytical
Precision Analytical is a CLIA certified laboratory run by a team of dedicated scientists with combined experience of over 50 years in performing laboratory tests and developing novel testing methods. We exist to make it easier for patients and their healthcare providers to find answers to complex clinical questions which affect their lives every day. Our unique hormone testing and reporting methods create better tools for healthcare providers to explore hormone issues with their patients. We are fully committed to the mission of improving the lives of those who trust us for their laboratory testing needs.


If you would like more information about this topic please call Amy Paoletti at 503-687-2050 or email